Vor Biopharma Inc. (VOR)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $131.18M
- P/E ratio
- —
- EPS
- —
- Volume
- 659,041
- 52-week high
- —
- 52-week low
- —
- Open
- $18.56
- Day high
- $18.66
- Day low
- $17.06
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$695.98M | -$70.50 |
| 2024 | — | -$116.91M | -$34.03 |
| 2023 | — | -$117.86M | -$1.75 |
| 2022 | — | -$92.09M | -$2.33 |
| 2021 | — | -$68.9M | -$2.10 |
About Vor Biopharma Inc.
Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is intended to enable a range of targeted blood cancer treatments, including CAR-T cell therapies, bispecific antibodies, and antibody-drug conjugates. Vor Biopharma has established a partnership with Akron BioProducts for the development and manufacturing of cGMP nucleases. Established in 2015, the company's headquarters are located in Cambridge, Massachusetts.
- CEO
- Jean-Paul Kress
- Employees
- 76
- Country
- US
- IPO date
- Feb 5, 2021
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Vor Biopharma Inc.'s stock price today?
- VOR is trading at $17.45 as of Jul 20, 2026.
- What is Vor Biopharma Inc.'s market cap?
- Vor Biopharma Inc. (VOR) has a market capitalization of $131.18M.
- Does Vor Biopharma Inc. pay a dividend?
- Vor Biopharma Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Vor Biopharma Inc. in?
- Vor Biopharma Inc. operates in the Healthcare sector.